REPROCELL Inc. is a Japan-based life science company centered on iPS cell technology, operating two core segments: Research Support and Medical. The Research Support segment provides iPS cell-related research reagents, human biosamples (including a ~600,000-specimen biobank via REPROCELL USA), contract research services, and cell measurement instruments to universities, public research institutes, and pharmaceutical companies globally. The Medical segment focuses on regenerative medicine product R&D (including Stemchymal for spinocerebellar degeneration, iPS-derived neural-glial cell products for ALS, TIL therapy, and GPC-1 CAR-T therapy), GMP-compliant iPS cell CDMO services, and clinical testing services including HLA typing and the 'Wellmill' mail-in hormone testing service.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →REPROCELL Inc. is a Japan-based life science company centered on iPS cell technology, operating two core segments: Research Support and Medical. The Research Support segment provides iPS cell-related research reagents, human biosamples (including a ~600,000-specimen biobank via REPROCELL USA), contract research services, and cell measurement instruments to universities, public research institutes, and pharmaceutical companies globally. The Medical segment focuses on regenerative medicine product R&D (including Stemchymal for spinocerebellar degeneration, iPS-derived neural-glial cell products for ALS, TIL therapy, and GPC-1 CAR-T therapy), GMP-compliant iPS cell CDMO services, and clinical testing services including HLA typing and the 'Wellmill' mail-in hormone testing service.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →